Industry
J3 Bioscience, Inc.
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed trials have results
Key Signals
2 with results
Enrollment Performance
Analytics
N/A
2(66.7%)
Early Phase 1
1(33.3%)
3Total
N/A(2)
Early Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT03150407Not ApplicableCompleted
Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness
Role: lead
NCT04288752Not ApplicableCompleted
Efficacy of VR101 as a Personal Lubricant
Role: lead
NCT02029053Early Phase 1Completed
Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness
Role: lead
All 3 trials loaded